Labitad, Rhen Heart L.
HRN: 21-93-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2024
CEFTRIAXONE 1G (VIAL)
03/31/2024
04/07/2024
IV DRIP
900mg
Q24
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes